← BackZomedica Corp. · DrugmakersZOMDF
Elevated riskNext report: In 6 days (est.)
The short versionA company still losing money with growing sales, with elevated risk. Institutions are trimming.
Going well
- Sales up 37% in the latest quarter vs a year ago
- Sales up 17% last year
- No debt reported
Watch out for
- About 6 months of cash left at its current burn
- Losing money, losses are large next to sales
Money moves
- No insider buying or selling in the last 30 days
- Institutions cut 91% from their holdings in the quarter ending June 2026 (2 bought, 3 sold)
Facts from SEC filings, not a recommendation.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$9.5M+37% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $36.9M, up 30% from the 12 months before.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.-52.6%
- PassDebt under half of equityNot relying on borrowed money.No debt reported
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-255.6%
- MissProfitable every yearSteady profits, not one good year.0 of 10 years
- MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$18.2M
- PassShare count not growingNot diluting owners. Falling means buybacks.0.0% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.67.7%
- Revenue
- $32.0M
- +17.4% vs prior year
- Total debt
- None
- 0.00x equity
- Current ratio
- 6.78x
- short-term assets / bills due
- Free cash flow
- -$18.2M
- -56.9% of revenue
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $9.5M
- +36.6% YoY
- EPS
- $0.00
- vs -$0.01
- Op. margin
- -42.9%
- +72.5 pts
- Gross margin
- 63.5%
- -3.5 pts
- Free cash flow
- -$2.6M
- Share count
- 0.0%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 0.4
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
▼Distributing-90.8%Institutions cut 90.8% from their holdings. 2 bought, 3 sold. 6 quarters of net selling in a row.
Shares held by institutions95K
Sep '24Jun '26
Share count growthYearly rate, last 3 years
0.0%Cash runwayAt last year's cash burn
5 monthsDebt to equityLatest balance sheet: debt compared with what owners have
No debt reportedShares outstandingLatest reported
980MWhy elevated risk- Losing money, losses are large next to sales
- About 5 months of cash left at its current burn
Next reportIn 6 days (est.)Estimated from the same quarter last year
- Results filedAug 5
- Results filedMay 6
- Results filedMar 16
- Results filedNov 4, 2025
- Results filedAug 6, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
Stock awardRussell Kevin KlassSr Vice President, Sales
250,000 shares
- Now owns 250,000 shares
- Exercise price $0.09
- Options to buy Common Stock
- Filed 2 days after trade
Stock awardKaren Dehaan-fullertonGeneral Counsel
250,000 shares
- Now owns 250,000 shares
- Exercise price $0.09
- Options to buy Common Stock
- Filed 2 days after trade
Stock awardAnthony K BlairCOO
500,000 shares
- Now owns 500,000 shares
- Exercise price $0.09
- Options to buy Common Stock
- Filed 2 days after trade
Quarterly reportAug 5 · Form 10-Q ↗Earnings resultsAug 5 · Form 8-K ↗Shareholder vote resultsJun 11 · Form 8-K ↗BoughtRussell Kevin KlassSr. Vice President, Sales
104,000 shares at $0.10 · $11K
- New position
- Now owns 104,000 shares
- Held spouse
- Filed NaN days after trade
BoughtRussell Kevin KlassInsider
216,899 shares at $0.11 · $23K
- +4% of holdings
- Now owns 6,001,000 shares
- 3 transactions
- Filed NaN days after trade
BoughtJohnny D PowersDirector
200,000 shares at $0.10 · $21K
- +5% of holdings
- Now owns 4,425,000 shares
- 3 transactions
- Filed NaN days after trade
Insider tradeMay 14 · Form 4 ↗Insider tradeMay 11 · Form 4 ↗Insider tradeMay 8 · Form 4 ↗Quarterly reportMay 6 · Form 10-Q ↗Earnings resultsMay 6 · Form 8-K ↗Proxy statementApr 27 · Form DEF 14A ↗